Applications of 5-Hydroxy-DL-Lysine Hydrochloride in Industrial Manufacturing

5-Hydroxy-DL-Lysine Hydrochloride serves as a high-purity specialty amino acid derivative with critical functional roles in several advanced industrial manufacturing sectors. Below, we detail its principal downstream applications, industry compliance factors, common usage ratios, process integration points, and related finished product categories.

1. Peptide Synthesis for Biomedical Research

Biomedical and pharmaceutical laboratories use 5-Hydroxy-DL-Lysine Hydrochloride as a protected amino acid building block for custom peptide and protein synthesis. Its hydroxylated lysine side chain mimics post-translational modifications found in collagen and other signaling peptides. During peptide assembly, synthetic chemists introduce this compound at precise sequence positions to study structural function, receptor binding, or cell signaling pathways. Preparation requires careful mitigation of racemization and control of chirality to ensure accurate target peptide activity, with batch QC by HPLC and MS assays. This application supports downstream R&D for wound healing, tissue engineering, and specialized protein interaction studies.

Industry compliance standards

• ICH Q7A Guideline for Active Pharmaceutical Ingredients
• US Pharmacopeia (USP) General Chapter <1045> on amino acid sequence fidelity
• ISO 13485 Medical Device Quality Management (for peptide-based diagnostic reagents)
• GLP and GMP certification for research and clinical use

Typical usage ratio

• 0.5–3 mol% per total amino acid load in solid-phase peptide synthesis
• Quantity adjusted based on peptide target length and amino acid composition

Downstream process integration

• Automated peptide synthesizer or manual synthetic protocol:
• Coupled during chain elongation cycles as Fmoc-protected derivative
• Deprotection and purification follow completed sequence assembly
• Purification by preparative RP-HPLC prior to biological application

Final product types

• Synthetic collagen-mimetic peptides
• Bioactive peptide standards
• Custom protein fragments for drug development
• Reference peptides for mass spectrometry analyses

2. Collagen Hydrolysate Manufacturing for Medical Devices

Producers of biomedical collagen hydrolysates incorporate 5-Hydroxy-DL-Lysine Hydrochloride to replicate the specific hydroxylation patterns found in natural tissues. The compound gets included at defined stages in the enzymatic hydrolysis and modification process. This supports applications where collagen composition, especially hydroxylysine content, directly influences bioactivity, cell adhesion, and wound-healing performance. The raw material requires thorough traceability documentation, as it directly affects the medical device’s matrix structure. Manufacturers carry out batch-wise quantitative amino acid analysis to ensure consistent product quality.

Industry compliance standards

• ISO 10993-1: Biological Evaluation of Medical Devices
• EN 13726-1: Test methods for primary wound dressings
• US FDA 21 CFR Part 820—Quality System Regulation for Medical Devices
• European Pharmacopeia (EP) 2.9.1 (for protein hydrolysate composition)

Typical usage ratio

• 0.1–1.2 g per 100 g collagen substrate
• Levels fine-tuned depending on application: higher for absorbable sponges; lower for film-based devices

Downstream process integration

• Added after primary collagen extraction and prior to controlled hydrolysis
• Mixing conducted under controlled pH and temperature to optimize side chain incorporation
• QC performed on post-hydrolysis amino acid composition
• Final product sterilized by gamma irradiation or ethylene oxide

Final product types

• Sterile collagen wound dressings
• Hemostatic collagen sponges
• Injectable collagen gels
• Collagen-based tissue scaffolds for regenerative medicine

3. Analytical Reference Standard Production

Certified reference material (CRM) manufacturers formulate 5-Hydroxy-DL-Lysine Hydrochloride as a calibration or validation standard for amino acid analysis, particularly in clinical and food laboratories. It provides a precise measurement benchmark for HPLC and LC-MS quantification of hydroxylated lysine residues in processed foods, dietary supplements, and biological fluids. Producers validate purity and isotopic labeling (where applicable) for use in trace and quantitative analysis. Lot-specific COAs and documentation for traceability are strictly maintained to meet analytical regulatory requirements.

Industry compliance standards

• ISO 17034: General requirements for reference material producers
• ISO/IEC 17025: Testing and calibration laboratory accreditation
• USP General Chapter <561> (Articles of Botanical Origin – Hydroxylysine determination)
• NIST and AOAC protocols for validated analytical reference materials

Typical usage ratio

• Concentration of 1–500 μg/mL as calibration points in aqueous standard solutions
• Concentration selected according to the analytical method sensitivity and sample matrix

Downstream process integration

• Dissolved in ultrapure water/buffer for calibration curves
• Sterile filtration and aliquoting into ampoules or vials
• Stability and homogeneity testing prior to batch release
• Provided as single- or multi-component mix for instrument validation

Final product types

• Certified amino acid reference solutions
• Multi-component CRM kits for clinical diagnostics
• QC materials for food supplement testing
• Internal standards for LC-MS/MS laboratories

4. Tissue Engineering Scaffold Formulation

Manufacturers of tissue engineering scaffolds utilize 5-Hydroxy-DL-Lysine Hydrochloride to achieve tailored crosslinking and biomimetic modification of synthetic polymer surfaces. The hydroxylated lysine derivative serves as a functional linker to enhance peptide/protein immobilization, modulate cell binding, and promote extracellular matrix interactions. Engineers add the raw material during the functionalization of base polymers or as a component in three-dimensional hydrogel precursor blends. The process requires strict monitoring for endotoxin and bioburden levels as well as full analytical characterization of modification efficiency.

Industry compliance standards

• ISO 22442-2: Animal tissue products used in medical devices
• FDA 510(k)/PMN submissions—biocompatibility and chemical modification reports
• USP General Chapter <87> Biological Reactivity Tests
• GMP for Advanced Therapy Medicinal Products (ATMPs)

Typical usage ratio

• 0.05–0.3% (w/w) in hydrogel or polymer scaffold blend
• Dose adjusted according to scaffold porosity and cell type targeted

Downstream process integration

• Blended with polymer matrix (e.g., PLGA, PEG, PDLLA) before crosslinking or molding
• Functionalized onto scaffold surfaces using EDC/NHS or carbodiimide chemistry
• Post-modification washing and endotoxin removal steps required
• Final sterilization and packaging in ISO Class 5 cleanroom

Final product types

• Bioactive polymer scaffolds for cell culture
• Tissue-engineered cartilage and bone grafts
• Skin regeneration matrix products
• Biodegradable hydrogels for clinical use